Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Willmann

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Applied Spectroscopy|April 24, 2004
Glucose quantification in dried-down nanoliter samples using mid-infrared attenuated total reflection spectroscopyEdgar Diessel, Stefan Willmann, Peter Kamphaus, et al.
Journal of Biomedical Optics|October 18, 2003
Small-volume frequency-domain oximetry: phantom experiments and first in vivo resultsStefan Willmann, Albert Terenji, Jens Osterholz, et al.
Journal of Pharmaceutical Sciences|October 14, 2011
Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutionsKirstin Thelen, Katrin Coboeken, Stefan Willmann, et al.
Current Pharmaceutical Design|September 2, 2015
Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo DataKarina Claassen, Kirstin Thelen, Katrin Coboeken, et al.
Clinical Pharmacokinetics|April 10, 2017
Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant WomenAndré Dallmann, Ibrahim Ince, Juri Solodenko, et al.
Handbook of Experimental Pharmacology|November 19, 2015
Modeling and Simulation of In Vivo Drug EffectsJörg Lippert, Rolf Burghaus, Lars Kuepfer, et al.
Theoretical Biology & Medical Modelling|March 28, 2007
Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) modelsMichaela Vossen, Michael Sevestre, Christoph Niederalt, et al.
Clinical Pharmacokinetics|June 29, 2016
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly IndividualsJan-Frederik Schlender, Michaela Meyer, Kirstin Thelen, et al.
Frontiers in Pharmacology|May 31, 2021
Comparing Predictions of a PBPK Model for Cyclosporine With Drug Levels From Therapeutic Drug MonitoringSonja E Zapke, Stefan Willmann, Scott-Oliver Grebe, et al.
The Journal of Pharmacy and Pharmacology|July 11, 2009
Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorptionStefan Willmann, Andrea N Edginton, Marcus Kleine-Besten, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Applied Spectroscopy|April 24, 2004
Glucose quantification in dried-down nanoliter samples using mid-infrared attenuated total reflection spectroscopyEdgar Diessel, Stefan Willmann, Peter Kamphaus, et al.
Journal of Biomedical Optics|October 18, 2003
Small-volume frequency-domain oximetry: phantom experiments and first in vivo resultsStefan Willmann, Albert Terenji, Jens Osterholz, et al.
Journal of Pharmaceutical Sciences|October 14, 2011
Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutionsKirstin Thelen, Katrin Coboeken, Stefan Willmann, et al.
Current Pharmaceutical Design|September 2, 2015
Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo DataKarina Claassen, Kirstin Thelen, Katrin Coboeken, et al.
Clinical Pharmacokinetics|April 10, 2017
Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant WomenAndré Dallmann, Ibrahim Ince, Juri Solodenko, et al.
Handbook of Experimental Pharmacology|November 19, 2015
Modeling and Simulation of In Vivo Drug EffectsJörg Lippert, Rolf Burghaus, Lars Kuepfer, et al.
Theoretical Biology & Medical Modelling|March 28, 2007
Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) modelsMichaela Vossen, Michael Sevestre, Christoph Niederalt, et al.
Clinical Pharmacokinetics|June 29, 2016
Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly IndividualsJan-Frederik Schlender, Michaela Meyer, Kirstin Thelen, et al.
Frontiers in Pharmacology|May 31, 2021
Comparing Predictions of a PBPK Model for Cyclosporine With Drug Levels From Therapeutic Drug MonitoringSonja E Zapke, Stefan Willmann, Scott-Oliver Grebe, et al.
The Journal of Pharmacy and Pharmacology|July 11, 2009
Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorptionStefan Willmann, Andrea N Edginton, Marcus Kleine-Besten, et al.
Pageof 8